| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |